Results 71 to 80 of about 393,653 (192)

MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling

open access: yesJournal of Hematology & Oncology, 2012
The discovery of miRNAs has revolutionized the way we examine the genome, RNA products, and the regulation of transcription and translation. Their ability to modulate protein expression through mRNA degradation and translation repression resulted in avid
Virtue Anthony   +2 more
doaj   +1 more source

Myeloid-derived suppressor cells and associated events in urethane-induced lung cancer [PDF]

open access: yes, 2013
OBJECTIVES: Myeloid-derived suppressor cells contribute to the immunosuppressive microenvironment during tumor development and limit the efficacy of cancer immunotherapy.
Almeida, Joaquim Soares de   +5 more
core   +5 more sources

TOLL LIKE RECEPTOR 4 (TLR4) AND DEMYELINATION

open access: yesIBRO Neuroscience Reports, 2023
Estefanía Sánchez-Jiménez   +12 more
doaj   +1 more source

Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation. [PDF]

open access: yes, 2018
Both adjuvants and focal ablation can alter the local innate immune system and trigger a highly effective systemic response. Our goal is to determine the impact of these treatments on directly treated and distant disease and the mechanisms for the ...
Borowsky, Alexander D   +13 more
core   +1 more source

Sequence variants of toll like receptor 4 and late-onset Alzheimer's disease.

open access: yesPLoS ONE, 2012
BackgroundToll like receptor 4 (TLR4) has been related to inflammation and beta-amyloid deposition in Alzheimer's disease (AD) brain. No study has explored the association between haplotype-tagging single nucleotide polymorphisms (htSNPs) of TLR4 and AD ...
Yen-Ching Chen   +6 more
doaj   +1 more source

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog [PDF]

open access: yes, 2009
Alcohol synergistically enhances the progression of liver disease and the risk for liver cancer caused by hepatitis C virus (HCV). However, the molecular mechanism of this synergy remains unclear.
Asahina, Kinji   +13 more
core   +2 more sources

Toll‐like receptor 4 polymorphisms in Saudi population with cardiovascular diseases

open access: yesMolecular Genetics & Genomic Medicine, 2019
Background Toll‐like receptors play a substantial role in innate immunity and the effects of TLR4 genetic variants on cardiovascular diseases are still largely unknown.
Abdelhabib Semlali   +11 more
doaj   +1 more source

Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients

open access: yesHaematologica, 2011
Background Signaling through the B-cell receptor appears to be a major contributor to the pathogenesis of chronic lymphocytic leukemia. Toll-like receptors bridge the innate and adaptive immune responses by acting as co-stimulatory signals for B cells ...
Eleni Arvaniti   +11 more
doaj   +1 more source

Hypoallergenic fragment of Par j 2 increases functional expression of Toll-like receptors in atopic children [PDF]

open access: yes, 2006
Parietaria judaica (Par j) is one of the main causes of allergy in the Mediterranean countries. The activation of Toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS) inhibits nasal inflammation of atopic ...
Bonsignore, G   +7 more
core   +1 more source

Toll‐like receptor expression during inflammatory processes in human diseases

open access: yesRheumatology & Autoimmunity
Multi‐cellular organisms, including humans, have evolved immune systems as defense mechanisms against pathogens. The immune system employs the Toll‐like receptor (TLR) family as its primary defensive mechanism against infections.
Prashant K. Dhakad   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy